Arnaub Chatterjee is Senior Vice President of Acorn AI, a Medidata company. Medidata is the global market leader in clinical data management in life sciences and in his role, Arnaub leads the development of data science products to advance research, development and commercialization. In addition to his role at Medidata, he also serves as Teaching Associate in the Department of Health Care Policy at Harvard Medical School and Lecturer in the Department of Policy Analysis and Management at Cornell University.
Prior to Medidata, Arnaub was Associate Partner in the Pharmaceutical and Medical Products group at McKinsey & Company, and Director of Merck's Data Science and Insights group. He served in the Obama Administration as an advisor to former Chief Technology Officers at the U.S. Department of Health and Human Services (HHS). His work has been published in journals such as the Harvard Business Review and Nature.
Artificial intelligence can help drug study teams solve operational, scientific and ethical challenges. For example, AI can be used to flag real-time trends emerging in drug trials that might otherwise not be obvious until the end of a study when all the data is analyzed.